531686 Stock Overview
MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
MPS Pharmaa Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹3.21 |
52 Week High | ₹3.21 |
52 Week Low | ₹2.10 |
Beta | -0.14 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | 52.86% |
3 Year Change | 217.82% |
5 Year Change | 73.51% |
Change since IPO | -72.42% |
Recent News & Updates
Recent updates
Shareholder Returns
531686 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0% | 1.4% | 2.8% |
1Y | 52.9% | 57.2% | 46.6% |
Return vs Industry: 531686 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 531686 exceeded the Indian Market which returned 46.6% over the past year.
Price Volatility
531686 volatility | |
---|---|
531686 Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531686 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 531686's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 18 | Peeyush Aggarwal | www.mpspharmaa.com |
MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products.
MPS Pharmaa Limited Fundamentals Summary
531686 fundamental statistics | |
---|---|
Market cap | ₹61.35m |
Earnings (TTM) | -₹9.02m |
Revenue (TTM) | ₹1.15m |
53.5x
P/S Ratio-6.8x
P/E RatioIs 531686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
531686 income statement (TTM) | |
---|---|
Revenue | ₹1.15m |
Cost of Revenue | ₹2.09m |
Gross Profit | -₹943.71k |
Other Expenses | ₹8.08m |
Earnings | -₹9.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.47 |
Gross Margin | -82.35% |
Net Profit Margin | -787.51% |
Debt/Equity Ratio | 290.5% |
How did 531686 perform over the long term?
See historical performance and comparison